Berry Genomics Co.,Ltd (SHE:000710)

Berry Genomics Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	359.91	383.07	338.15	333.56	417.89	629.31
Trading Asset Securities	10.48	17.03	13.86	4.51	3.82	3.82
Cash & Short-Term Investments	370.39	400.1	352.01	338.07	421.7	633.12
Cash Growth	21.83%	13.66%	4.12%	-19.83%	-33.39%	35.19%
Accounts Receivable	666.74	694.72	815.21	1,063	1,109	1,071
Other Receivables	75.11	76.45	4.97	14.51	34.07	45.71
Receivables	741.85	771.17	820.18	1,077	1,143	1,117
Inventory	196.99	194.91	229.3	230.95	233.88	180.27
Prepaid Expenses	-	0.01	0.14	0.21	1.88	2.92
Other Current Assets	73.83	72.9	71.37	80.15	105.88	74.65
Total Current Assets	1,383	1,439	1,473	1,727	1,907	2,008
Property, Plant & Equipment	540.84	459.07	923.42	1,101	1,131	909.28
Long-Term Investments	182.67	177.19	48.45	138.26	279.07	167.14
Goodwill	13.43	13.43	13.43	13.43	13.43	13.43
Other Intangible Assets	29.53	31.68	49.67	51.6	52.21	53.9
Long-Term Deferred Tax Assets	145.67	144.07	151.27	104.8	63.93	26.36
Long-Term Deferred Charges	96.47	89.77	48.44	41.04	46.71	46.81
Other Long-Term Assets	30.11	30.42	33.49	26.66	27.05	19
Total Assets	2,422	2,385	2,741	3,203	3,520	3,244
Accounts Payable	245.9	287.51	292.48	278.9	339.93	243.29
Accrued Expenses	39.89	55.81	64.95	63.14	66.16	74.04
Short-Term Debt	162.62	113.42	202.64	203.69	190.54	123.11
Current Portion of Long-Term Debt	-	-	42.3	-	-	-
Current Portion of Leases	4.65	3.63	12.95	13	9.44	-
Current Income Taxes Payable	3.18	3.9	11.91	0.38	13.44	18.15
Current Unearned Revenue	94.44	103.49	110.75	103.56	90.55	71.19
Other Current Liabilities	18.86	22.81	25.11	42.05	58.52	26.66
Total Current Liabilities	569.55	590.56	763.09	704.72	768.58	556.43
Long-Term Debt	-	-	42.18	126.6	185.7	236.34
Long-Term Leases	134.92	43.24	3.5	4.88	13.62	-
Long-Term Unearned Revenue	10.94	10.87	11.02	12.07	3.66	4.85
Long-Term Deferred Tax Liabilities	25.85	24.9	26.77	25.89	24.46	23.91
Total Liabilities	741.26	669.56	846.56	874.17	996.02	821.52
Common Stock	353.52	353.52	353.52	354.61	354.61	354.61
Additional Paid-In Capital	1,154	1,159	1,156	1,211	1,160	1,061
Retained Earnings	118.15	145.39	337.82	765.02	1,020	1,131
Treasury Stock	-	-	-	-44.52	-44.52	-160.42
Comprehensive Income & Other	17.8	21.1	16.5	15.39	0.63	2.73
Total Common Equity	1,644	1,679	1,864	2,301	2,490	2,388
Minority Interest	36.86	35.69	30.57	27.94	33.51	34.01
Shareholders' Equity	1,681	1,715	1,895	2,329	2,524	2,422
Total Liabilities & Equity	2,422	2,385	2,741	3,203	3,520	3,244
Total Debt	302.2	160.28	303.58	348.17	399.3	359.44
Net Cash (Debt)	68.19	239.82	48.43	-10.11	22.4	273.68
Net Cash Growth	-53.44%	395.21%	-	-	-91.81%	28.94%
Net Cash Per Share	0.19	0.68	0.14	-0.03	0.06	0.77
Filing Date Shares Outstanding	353.52	353.52	353.52	353.52	353.52	350.7
Total Common Shares Outstanding	353.52	353.52	353.52	353.52	353.52	350.7
Working Capital	813.5	848.53	709.9	1,022	1,138	1,452
Book Value Per Share	4.65	4.75	5.27	6.51	7.04	6.81
Tangible Book Value	1,601	1,634	1,801	2,236	2,425	2,321
Tangible Book Value Per Share	4.53	4.62	5.09	6.33	6.86	6.62
Buildings	317.47	317.47	606.22	684.23	684.08	691.39
Machinery	637.38	623.32	638.82	591.45	553.45	542.23
Construction In Progress	5.71	-	230.8	290.95	267.6	3.75

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.